Neoadjuvant weekly paclitaxel and carboplatin with trastuzumab and pertuzumab in HER2-positive breast cancer: a Brown University Oncology Research Group (BrUOG) study
Lopresti, M. L., Bian, J. J., Sakr, B. J., Strenger, R. S., Legare, R. D., Fenton, M., Witherby, S. M., Dizon, D. S., Pandya, S. V., Stuckey, A. R., Edmondson, D. A., Gass, J. S., Emmick, C. M., Graves, T. A., Cutitar, M., Olszewski, A. J., Sikov, W. M.
Published in Breast cancer research and treatment (01.08.2021)
Published in Breast cancer research and treatment (01.08.2021)
Get full text
Journal Article
Neoadjuvant weekly paclitaxel and carboplatin with trastuzumab and pertuzumab in HER2-positive breast cancer: a Brown University Oncology Research Group
Fenton, M, Sakr, B. J, Witherby, S. M, Bian, J. J, Strenger, R. S, Lopresti, M. L, Legare, R. D
Published in Breast cancer research and treatment (01.08.2021)
Get full text
Published in Breast cancer research and treatment (01.08.2021)
Journal Article